Health & BiotechNovo Nordisk Exits Cell Therapy, Hands Parkinson's Program to AI Startup as NVIDIA Locks In Global Pharma DealsVia News Editorial Team•Jun 5, 2026
Health & ScienceNovo Nordisk Shares Surge 24.9% as Global Pharma Abandons Wet Labs for AIVia News Editorial Team•May 13, 2026